Home/ Supplements/ Dim/ DIM SGS+

DIM SGS+

product on market Capsule BioTe Nutraceutical Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Diindolylmethane and sulforaphane glucosinolate are researched for their roles in estrogen metabolism and cellular detoxification, though clinical evidence for these specific formulations remains limited. Pomegranate extract provides antioxidant properties supported by moderate research. The ingredient profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DIM SGS+
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (3 products) 11 studies (A:1, B:3)
Market median: 250.0mg (182 products) 10 studies (A:0, B:2)
Market median: 30.0mg (12 products) 5 studies — no high-quality reviews

Other Ingredients

Hypromellose Calcium Laurate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take 1 capsule one to two times daily with food, or as recommended by your healthcare practitioner.

Warnings & Precautions

Tamper evident: Use only if bottle is sealed.

Warnings: Keep out of reach of children.

If pregnant, nursing, or trying to conceive, consult your healthcare practitioner before using this product.

Formulation Notes

Free from: Soy, dairy, gluten

Hormone Detox

Additional Information

Store tightly sealed in a cool, dry place.

Metadata

Product Details

UPC / SKU8 50026 84008 7
DSLD Entry Date2025-09-25
Product TypeOther Combinations
FormCapsule
DSLD ID338466
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Compare

Similar Products

View all Dim products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.